Iontophoretic administration of prostaglandin E1 in peripheral arterial occlusive disease

被引：1
|
作者：
Sakurai, T [1 ]
Yamamura, K
机构：
[1] Nagoya Univ, Sch Med, Dept Vasc Surg, Nagoya, Aichi 466, Japan
[2] Nagoya Univ, Sch Pharm, Dept Hosp Pharm, Showa Ku, Nagoya, Aichi 4668560, Japan
来源：
ANNALS OF PHARMACOTHERAPY | 2003年 / 37卷 / 05期
关键词：
D O I：
10.1345/aph.1C367
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：747 / 747
页数：1
相关论文
共 50 条
  • [1] Mechanisms of anti-ischemic action of prostaglandin E1 in peripheral arterial occlusive disease
    Schrör, K
    Hohlfeld, T
    VASA-JOURNAL OF VASCULAR DISEASES, 2004, 33 (03): : 119 - 124
  • [2] Intra-arterial and intravenous administration of prostaglandin E1 cause different changes to skin microcirculation in patients with peripheral arterial occlusive disease
    Thum, J
    Caspary, L
    Creutzig, A
    Alexander, K
    VASA-JOURNAL OF VASCULAR DISEASES, 1998, 27 (02): : 100 - 105
  • [3] Iontophoretic application of prostaglandin E1 for improvement in peripheral microcirculation
    Saeki, S
    Yamamura, K
    Masushita, M
    Nishikimi, N
    Sakurai, T
    Nimura, Y
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1998, 36 (10) : 525 - 529
  • [4] Clinical and haemostatic effects of intravenous prostaglandin E1 therapy in patients with peripheral arterial occlusive disease
    Trifiletti, A
    Scamardi, R
    Pizzoleo, MA
    Sottilotta, G
    Soraci, S
    Attina, A
    Bagnato, L
    Barbera, N
    PANMINERVA MEDICA, 1999, 41 (01) : 15 - 17
  • [5] PROSTAGLANDIN-E1 IN THE THERAPY OF PERIPHERAL ARTERIAL OCCLUSIVE DISEASE
    SINZINGER, H
    ROGATTI, W
    WIENER KLINISCHE WOCHENSCHRIFT, 1991, 103 (18) : 558 - 565
  • [6] Iontophoretic application of prostaglandin E1
    Saeki, S
    Yamamura, K
    Osada, T
    Hayashi, T
    Koyasu, K
    Nabeshima, T
    Nishikimi, N
    Sakurai, T
    23RD INTERNATIONAL SYMPOSIUM ON CONTROLLED RELEASE OF BIOACTIVE MATERIALS, 1996 PROCEEDINGS, 1996, : 707 - 708
  • [7] Mode of action of prostaglandin E1 in the treatment of peripheral arterial disease
    Weiss, T
    VASA-JOURNAL OF VASCULAR DISEASES, 2003, 32 (04): : 187 - 192
  • [8] Prostaglandin E1 versus lumbar sympathectomy in the treatment of peripheral arterial occlusive disease:: randomised study of 86 patients
    Petronella, P
    Freda, F
    Nunziata, L
    Antropoli, M
    Manganiello, A
    Cutolo, PP
    D'Amodio, AS
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2004, 14 (04) : 186 - 192
  • [9] EFFECTS OF INTRAARTERIAL PROSTAGLANDIN-E1 IN PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE
    CREUTZIG, A
    CREUTZIG, H
    ALEXANDER, K
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1986, 16 (06) : 480 - 485
  • [10] Meta-analysis of randomised controlled prostaglandin E1 studies in peripheral arterial occlusive disease stages III and IV
    Creutzig, A
    Lehmacher, W
    Elze, M
    VASA-JOURNAL OF VASCULAR DISEASES, 2004, 33 (03): : 137 - 144
12345